AFP and hepatocellular carcinoma: Consistent with clinical perceptions, AFP and PIVKA-II were higher in HCC than that in non-HCC patients (Supplementary Fig. 1h), and MS quantitative proteomic results of AFP showed a high correlation with clinical antibody-based assays (Fig. 3e, f).